Created in 1958 (Switzerland), CEDILANID own 2951 sister brands and 17477 competing brands. The CEDILANID brand is owned by NOVARTIS N, a company listed in Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. The sector of CEDILANID is Drug Manufacturers.

CEDILANID is a brand of NOVARTIS N (NOVN) Share price

Share price and profitability of the share NOVARTIS N (CEDILANID)

Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 84.85

Portfolio valuation
NOVARTIS N (CEDILANID) over 5 years* CHF 98.05

Stock market history NOVARTIS N (CEDILANID)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more